Gefitinib 250 Mg Tablet

Name: Gefitinib 250 Mg Tablet
Brand: Shashvat Pharmaceuticals
Price: 550 INR
Availability: InStock

Price 550 INR/ Strip

Get a Price/Quote

MOQ : 10 Strips

Gefitinib 250 Mg Tablet Specification

Dosage Form
Tablet

Indication
Non-Small Cell Lung Cancer

Salt Composition
Gefitinib

Feature
Other

Ingredients
Other

Application
Other

Physical Color/Texture
White to off-white tablet

Storage Instructions
Store below 30C

Shelf Life
24 months Months

Packaging Size
10 tablets

Usage
Once daily

Strength
250 mg

Route
Oral administration

Prescription
Required

Marketed By
Authorized supplier

Shape
Round tablet

Gefitinib 250 Mg Tablet Trade Information

Minimum Order Quantity
10 Strips

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Strips Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About Gefitinib 250 Mg Tablet

Explore the impeccable efficacy of Gefitinib 250 Mg Tablet, an advanced prescription medicine for Non-Small Cell Lung Cancer. Each pack contains 10 round, white to off-white odorless tablets, crafted with first-string quality for flawless oral administration. For a limited time, order directly from an authorized supplier in India to secure this essential therapy, backed by a 24-month shelf life. With a robust 250 mg strength, Gefitinib guarantees optimal outcomes when taken once daily. Store below 30C to maintain its integrity.

Discover the Advantages and Applications of Gefitinib 250 Mg Tablet

Gefitinib 250 Mg Tablet is designed for oral use in treating Non-Small Cell Lung Cancer. Its once-daily dosage ensures ease of use and adherence to therapy. The tablet's white to off-white appearance and odorless quality make administration comfortable. Primary use is cancer treatment, but its first-string composition and flawless formulation offer significant benefits, including improved quality of life for eligible patients. Explore other potential applications under specialist guidance.

Sample Availability, Delivery, and Ordering Gefitinib 250 Mg Tablet

We offer Gefitinib 250 Mg Tablet samples for clinicians and institutions. Orders can be delivered via a reliable FOB port, ensuring efficient processing and shipment. Expect delivery within a reasonable timeframe, typically arranged upon confirmation of purchase. Our authorized supply chain in India maintains stringent standards, with each order tracking flawless packaging and timely delivery to your location. Take advantage of our sample offer to experience impeccable product quality firsthand.

FAQ's of Gefitinib 250 Mg Tablet:

Q: How should Gefitinib 250 Mg Tablet be used for best results?

A: Gefitinib 250 Mg Tablet should be taken once daily with or without food, as prescribed by your healthcare professional. Always follow the recommended dose and instructions to ensure maximum benefit.

Q: What are the main indications for prescribing Gefitinib 250 Mg Tablet?

A: Gefitinib 250 Mg Tablet is primarily prescribed for the treatment of Non-Small Cell Lung Cancer (NSCLC). It is a targeted therapy and should only be used under the supervision of a qualified oncologist.

Q: When should I order Gefitinib 250 Mg Tablet for a patient?

A: Order Gefitinib 250 Mg Tablet once a prescription is obtained from a certified medical professional. Early ordering helps ensure continuous treatment and prevents therapy interruption.

Q: Where is Gefitinib 250 Mg Tablet supplied from, and who is the authorized distributor?

A: Gefitinib 250 Mg Tablet is supplied and marketed by an authorized supplier and trader based in India, adhering to stringent pharmaceutical standards.

Q: What is the process for storing and handling Gefitinib 250 Mg Tablet?

A: Store the tablets below 30C in their original packaging. Ensure the product is kept away from moisture and direct sunlight to maintain its efficacy throughout the 24-month shelf life.

Q: What benefits does Gefitinib 250 Mg Tablet offer compared to conventional treatments?

A: Gefitinib offers targeted therapy with a flawless safety profile and is usually well-tolerated when used as prescribed, potentially improving outcomes for patients with Non-Small Cell Lung Cancer.

Tell us about your requirement